億田智能(300911.SZ):調整部分募投項目募集資金投資額
格隆匯 12 月 25日丨億田智能(300911.SZ)公佈,公司於2020年12月24日召開第二屆董事會第三次會議和第二屆監事會第二次會議,審議通過了《關於調整部分募投項目募集資金投資額的議案》,同意公司根據首次公開發行股票募集資金實際情況,對募投項目募集資金具體投資金額進行相應調整。
由於此次公開發行實際募集資金淨額59495.81萬元少於擬投入的募集資金金額78271.10萬元,為保障募集資金投資項目的順利實施,提高募集資金的使用效率,結合公司實際情況,對部分募集資金投資項目投資金額進行調整,具體情況如下:

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.